Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.1M Buy
93,866
+428
+0.5% +$50.1K 2.11% 13
2026
Q1
$11.2M Buy
93,438
+480
+0.5% +$55.4K 2.11% 12
2025
Q4
$9.78M Buy
92,958
+2,596
+3% +$244K 1.85% 14
2025
Q3
$7.58M Buy
90,362
+1,189
+1% +$97.9K 1.46% 20
2025
Q2
$7.06M Sell
89,173
-1,077
-1% -$85.6K 1.42% 22
2025
Q1
$8.1M Sell
90,250
-344
-0.4% -$32.1K 1.75% 16
2024
Q4
$9.01M Sell
90,594
-2,107
-2% -$217K 1.96% 14
2024
Q3
$10.5M Sell
92,701
-225
-0.2% -$26.7K 2.23% 12
2024
Q2
$11.5M Buy
92,926
+2,741
+3% +$353K 2.59% 10
2024
Q1
$11.9M Sell
90,185
-4,431
-5% -$546K 2.75% 9
2023
Q4
$10.3M Sell
94,616
-1,692
-2% -$176K 2.51% 9
2023
Q3
$9.91M Sell
96,308
-3,180
-3% -$343K 2.62% 9
2023
Q2
$11.5M Sell
99,488
-336
-0.3% -$38.1K 2.94% 8
2023
Q1
$10.6M Sell
99,824
-1,512
-1% -$163K 2.79% 10
2022
Q4
$11.2M Sell
101,336
-3,617
-3% -$370K 2.94% 8
2022
Q3
$9.04M Buy
104,953
+654
+0.6% +$58.4K 2.64% 10
2022
Q2
$9.51M Sell
104,299
-935
-0.9% -$82.9K 2.59% 10
2022
Q1
$8.63M Buy
105,234
+164
+0.2% +$12.9K 2.09% 13
2021
Q4
$8.05M Buy
105,070
+2,862
+3% +$228K 1.9% 17
2021
Q3
$7.68M Buy
102,208
+2,473
+2% +$188K 1.99% 16
2021
Q2
$7.76M Sell
99,735
-6,028
-6% -$448K 1.99% 16
2021
Q1
$7.78M Sell
105,763
-2,398
-2% -$177K 2.1% 11
2020
Q4
$8.44M Buy
108,161
+919
+0.9% +$70.3K 2.3% 10
2020
Q3
$8.49M Sell
107,242
-475
-0.4% -$37.2K 2.54% 9
2020
Q2
$7.95M Sell
107,717
-2,215
-2% -$167K 2.57% 9
2020
Q1
$8.07M Sell
109,932
-8
-0% -$629 2.97% 8
2019
Q4
$9.54M Buy
109,940
+5,381
+5% +$442K 2.74% 8
2019
Q3
$8.4M Buy
104,559
+667
+0.6% +$53.5K 2.57% 9
2019
Q2
$8.31M Sell
103,892
-1,208
-1% -$92.5K 2.7% 11
2019
Q1
$8.34M Buy
105,100
+1,339
+1% +$100K 2.77% 10
2018
Q4
$7.57M Buy
103,761
+364
+0.4% +$25.7K 2.82% 9
2018
Q3
$7M Sell
103,397
-2,083
-2% -$133K 2.36% 13
2018
Q2
$6.11M Buy
105,480
+8,508
+9% +$480K 2.21% 14
2018
Q1
$5.04M Sell
96,972
-113
-0.1% -$6.1K 1.93% 20
2017
Q4
$5.21M Sell
97,085
-4,294
-4% -$238K 1.95% 19
2017
Q3
$6.19M Buy
101,379
+3,199
+3% +$194K 2.46% 12
2017
Q2
$6M Buy
98,180
+7,713
+9% +$470K 2.37% 11
2017
Q1
$5.49M Buy
90,467
+4,237
+5% +$257K 2.24% 13
2016
Q4
$4.84M Buy
86,230
+3,695
+4% +$216K 2.04% 14
2016
Q3
$4.92M Buy
82,535
+1,820
+2% +$106K 2.16% 12
2016
Q2
$4.44M Buy
80,715
+13,209
+20% +$703K 1.98% 13
2016
Q1
$3.41M Sell
67,506
-1,876
-3% -$91.9K 1.62% 19
2015
Q4
$3.5M Sell
69,382
-1,066
-2% -$53.7K 1.79% 18
2015
Q3
$3.32M Buy
70,448
+1,148
+2% +$61K 1.84% 16
2015
Q2
$3.77M Buy
69,300
+4,848
+8% +$272K 1.97% 16
2015
Q1
$3.54M Buy
64,452
+3,502
+6% +$198K 1.86% 18
2014
Q4
$3.3M Buy
60,950
+2,910
+5% +$162K 1.78% 20
2014
Q3
$3.28M Buy
58,040
+3,040
+6% +$171K 1.84% 18
2014
Q2
$3.04M Sell
55,000
-182
-0.3% -$9.93K 1.73% 21
2014
Q1
$2.99M Buy
55,182
+1,353
+3% +$70.1K 1.76% 20
2013
Q4
$2.57M Buy
53,829
+351
+0.7% +$16K 1.54% 24
2013
Q3
$2.43M Buy
53,478
+21,806
+69% +$996K 1.62% 21
2013
Q2
$1.4M Buy
+31,672
New +$1.41M 0.97% 34

Other funds holding MRK

Lynch & Associates's MRK Position: Q2 2026 in Review

Lynch & Associates increased its Merck (MRK) stake by 0.46% in Q2 2026, buying an estimated $50.1K and bringing the position to 93,866 shares worth $12.1M. The position accounts for 2.11% of the portfolio, ranked #13.

Lynch & Associates first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Lynch & Associates held 93,866 shares of Merck worth $12.1M as of Q2 2026.
  • Lynch & Associates bought 428 Merck shares in Q2 2026, an estimated $50.1K.
  • Merck made up 2.11% of Lynch & Associates's portfolio in Q2 2026, its #13 holding.
  • Lynch & Associates first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Lynch & Associates's 13F filing for Q2 2026, filed 13 Jul 2026.